Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Contact information

Email
samuel.acreman@ocdem.ox.ac.uk

Research groups

Rorsman Group

Samuel Acreman

Postdoctoral Research Assistant

Recent publications

ntecedent hypoglycaemia impairs glucagon secretion by enhancing somatostatin-mediated negative feedback control.

Gao R. et al, (2026), Nat Metab, 8, 159 - 176

Loss of electrical β-cell to δ-cell coupling underlies impaired hypoglycaemia-induced glucagon secretion in type-1 diabetes.

Hill TG. et al, (2024), Nat Metab, 6, 2070 - 2081

Perlecan: An Islet Basement Membrane Protein with Protective Anti-Inflammatory Characteristics.

Brandhorst D. et al, (2024), Bioengineering (Basel), 11

The endoplasmic reticulum plays a key role in α-cell intracellular Ca2+ dynamics and glucose-regulated glucagon secretion in mouse islets.

Acreman S. et al, (2024), iScience, 27

GLP-1 metabolite GLP-1(9-36) is a systemic inhibitor of mouse and human pancreatic islet glucagon secretion.

Gandasi NR. et al, (2024), Diabetologia, 67, 528 - 546

More publications